|
Published by: Global Markets Direct
Published: Mar. 27, 2009 - 91 Pages
Table of Contents
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 3 Definitions of Markets Covered in This Report
- 3.1 Drug delivery devices
- 3.2 Needle-free Injections
- 3.3 Inhalation Systems
- 3.3.1 Metered Dose Inhaler
- 3.3.2 Dry powder inhaler
- 3.4 Infusion Systems
- 3.4.1 Infusion pumps
- 3.4.2 Syringe pumps
- 3.4.3 Disposable Infusion sets
- 4 Healthcare Sector Review
- 4.1 Healthcare Expenditure
- 4.2 Healthcare Infrastructure
- 4.3 Healthcare Policy
- 5 Regulation System
- 5.1 Medical Equipment Approval Process
- 5.1.1 Market Authorization Holder (MAH)
- 5.1.2 Classification and Pre-Market Approval of Medical Devices
- 5.1.3 Third Party Certification for Controlled Medical Devices
- 5.1.4 PMDA Approval for Highly Controlled Medical Devices
- 5.1.5 Registration Time
- 5.1.6 Registration Fee
- 5.1.7 Post Marketing Surveillance
- 5.1.8 Labeling and Packaging
- 6 Pricing and Reimbursement
- 6.1 Market Pricing
- 6.2 Reimbursement Policies
- 6.3 Reimbursement Classes
- 6.3.1 Class A
- 6.3.2 Class B
- 6.3.3 Class C
- 6.3.4 Class F
- 6.4 Request for Reimbursement
- 6.5 Reduction in Reimbursement for Medical Devices and Drugs
- 7 Distribution Structure
- 8 Drug Delivery Devices In Japan
- 8.1 Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
- 8.2 Drug Delivery Devices, Japan, Overall Revenue ($ mn), 2000-2015
- 8.3 Drug Delivery Devices, Japan, Category Volume (Units), 2000-2015
- 8.4 Drug Delivery Devices, Japan, Company Share (2006-2007)
- 9 Infusion Systems In Japan
- 9.1 Infusion Systems Overall Revenue (2000-2015)
- 9.2 Infusion Systems Overall Volume (2000-2015)
- 9.3 Infusion Systems Average Price (2000-2015)
- 9.4 Infusion Systems Distribution Share (2007-2008)
- 9.5 Infusion Systems, Japan, Company Share (2006-2007)
- 10 Inhalation Systems In Japan
- 10.1 Inhalation Systems Overall Revenue (2000-2015)
- 10.2 Inhalation Systems Overall Volume (2000-2015)
- 10.3 Inhalation Systems Average Price (2000-2015)
- 10.4 Inhalation Systems Distribution Share (2007-2008)
- 10.5 Inhalation Systems, Japan, Company Share (2006-2007)
- 11 Needle Free Injections In Japan
- 11.1 Needle Free Injections Overall Revenue (2000-2015)
- 11.2 Needle Free Injections Overall Volume (2000-2015)
- 11.3 Needle Free Injections Average Price (2000-2015)
- 11.4 Needle Free Injections Distribution Share (2007-2008)
- 11.5 Needle Free Injections, Japan, Company Share (2006-2007)
- 12 Overview of Key Companies in Japan Drug Delivery Devices Market
- 12.1 AstraZeneca PLC Company Profile
- 12.1.1 Company Overview
- 12.2 GlaxoSmithKline plc Company Profile
- 12.2.1 Company Overview
- 12.3 Boehringer Ingelheim GmbH Company Profile
- 12.3.1 Company Overview
- 12.3.2 Value Chain Analysis
- 12.3.2.1 Manufacturing
- 12.3.2.2 Product Development
- 12.3.2.3 Sales and Marketing
- 12.4 Cardinal Health, Inc. Company Profile
- 12.4.1 Company Overview
- 12.4.2 Value Chain Analysis
- 12.4.2.1 Manufacturing
- 12.4.2.2 Product Development
- 12.4.2.3 Sales and Marketing
- 12.5 Novartis AG
- 12.5.1 Company Overview
- 12.6 Baxter International Inc. Company Profile
- 12.6.1 Company Overview
- 12.6.2 Value Chain Analysis
- 12.6.2.1 Manufacturing
- 12.6.2.2 Product Development
- 12.6.2.3 Sales and Marketing
- 12.7 Hospira, Inc. Company Profile
- 12.7.1 Company Overview
- 12.7.2 Value Chain Analysis
- 12.7.2.1 Manufacturing
- 12.7.2.2 Product Development
- 12.7.2.3 Research and Development
- 12.7.2.4 Sales and Marketing
- 12.7.3 Hospira, Inc. Pipeline Products
- 12.7.3.1 Hospira, Inc. Pipeline Products by Equipment Type
- 12.7.3.2 Hospira, Inc. Pipeline Products by Development Stage
- 12.7.3.3 Hospira, Inc. Pipeline Products by Therapy Area
- 12.8 Smiths Medical Company Profile
- 12.8.1 Company Overview
- 12.8.2 Value Chain Analysis
- 12.8.2.1 Manufacturing
- 12.8.2.2 Product Development
- 12.8.2.3 Sales and Marketing
- 12.9 Consort Medical plc Company Profile
- 12.9.1 Company Overview
- 12.9.2 Value Chain Analysis
- 12.9.2.1 Manufacturing
- 12.9.2.2 Product Development
- 12.9.2.3 Sales and Marketing
- 12.9.3 Consort Medical plc Pipeline Products
- 12.9.3.1 Consort Medical plc Pipeline Products By Equipment Type
- 12.9.3.2 Consort Medical plc Pipeline Products By Development Stage
- 12.9.3.3 Consort Medical plc Pipeline Products By Therapy Area
- 12.10 B. Braun Melsungen AG Company Profile
- 12.10.1 Company Overview
- 12.10.2 Value Chain Analysis
- 12.10.2.1 Manufacturing
- 12.10.2.2 Product Development
- 12.10.2.3 Research and Development
- 12.10.2.4 Sales and Marketing
- 12.11 Bioject Medical Technologies Inc.
- 12.11.1 Company Overview
- 12.11.2 Value Chain Analysis
- 12.11.2.1 Manufacturing
- 12.11.2.2 Product Development
- 12.11.2.3 Sales and Marketing
- 12.12 Daiken Medical Co., Ltd. Company Profile
- 12.12.1 Company Overview
- 12.13 TOP Corporation Company Profile
- 12.13.1 Company Overview
- 13 Appendix
- 13.1 Global Markets Direct Research Methodology
- 13.2 Coverage
- 13.3 Secondary Research
- 13.4 Primary Research
- 13.5 Models
- 13.6 Forecasts
- 13.7 Expert Panel Validation
- 13.8 Currency Conversion
- 13.9 Contact Us
- 13.10 Disclaimer
AbstractJapan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to the Japan drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Japan
Scope- The report provides drug delivery devices information broken down into detailed categories and segments in Japan.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy- Gain a strong understanding of the drug delivery devices market in Japan.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2009
|